Literature DB >> 25923758

The long-term outcome after acute kidney injury: a narrative review.

Luana Pôncio1, Andre Luis Balbi1, Érica Pires da Rocha1, Dayana Bitencourt Dias1, Daniela Ponce1.   

Abstract

This review will focus on long-term outcomes after acute kidney injury (AKI). Surviving AKI patients have a higher late mortality compared with those admitted without AKI. Recent studies have claimed that long-term mortality in patients after AKI varied from 15% to 74% and older age, presence of previous co-morbidities, and the incomplete recovery of renal function have been identified as risk factors for reduced survival. AKI is also associated with progression to chronic kidney (CKD) disease and the decline of renal function at hospital discharge and the number and severity of AKI episodes have been associated with progression to CKD. IN the most studies, recovery of renal function is defined as non-dependence on renal replacement therapy which is probably too simplistic and it is expected in 60-70% of survivors by 90 days. Further studies are needed to explore the long-term prognosis of AKI patients.

Entities:  

Mesh:

Year:  2015        PMID: 25923758     DOI: 10.5935/0101-2800.20150016

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  3 in total

1.  Outcomes of acute kidney injury in a nephrology ward.

Authors:  Ana R Fernandes; Márcio S R Viegas; Elsa Q Soares; Sofia S Coelho; Patricia Valério; José C Barreto; José M Vinhas
Journal:  Int Urol Nephrol       Date:  2017-10-11       Impact factor: 2.370

2.  Short-term renal outcomes following acute kidney injury among dengue patients: A follow-up analysis from large prospective cohort.

Authors:  Tauqeer Hussain Mallhi; Amer Hayat Khan; Azreen Syazril Adnan; Azmi Sarriff; Yusra Habib Khan; Siew Hua Gan
Journal:  PLoS One       Date:  2018-02-26       Impact factor: 3.240

3.  Organophosphate Poisoning and Subsequent Acute Kidney Injury Risk: A Nationwide Population-Based Cohort Study.

Authors:  Feng-You Lee; Wei-Kung Chen; Cheng-Li Lin; Ching-Yuan Lai; Yung-Shun Wu; I-Ching Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.